Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Gilead Sciences: What If Sovaldi Sales Peak Quickly, Fall Fast?
Barron's
Wed, 04/2/14 - 09:41 pm
Tags:
Sovaldi, hepatitis C, Gilead Sciences
Biotechnology companies hunting for the keys to immortality
FT.com
Thu, 03/27/14 - 05:09 pm
Tags:
Mesoblast, aging, Calico, AlloCure, stem cells, Gilead Sciences
Congress Makes Sovaldi A Scapegoat: The Cost-Innovation Paradox In The US Healthcare System
Forbes
Thu, 03/27/14 - 10:58 am
Tags:
Gilead Sciences, drug pricing, Sovaldi, US Congress
Large Cap Biopharmaceuticals Are Core Holdings After Sell-Off: AbbVie, Amgen, Gilead
Seeking Alpha
Wed, 03/26/14 - 08:30 am
Tags:
AbbVie, Amgen, Gilead Sciences, Achillion, Alexion, Ariad Pharmaceuticals, Pharmacyclics, Seattle Genetics
Gilead Following Multiple Paths Toward HIV “Functional Cure”
Motley Fool
Tue, 03/25/14 - 08:01 pm
Tags:
Gilead Sciences, HIV
Will The Hep-C Drug, Sovaldi, Drive Gilead To The Top Of The Biopharm Industry?
Forbes
Tue, 03/25/14 - 08:05 am
Tags:
hepatitis C, Gilead Sciences, Sovaldi
Sovaldi's Patent War
Seeking Alpha
Mon, 03/24/14 - 06:00 pm
Tags:
Sovaldi, Gilead Sciences, hepatitis C, patents
JPMorgan Sees No Bubble, Hears No Bubble as Biotech Falls Again
Barron's
Mon, 03/24/14 - 11:29 am
Tags:
biotech, Biogen Idec, Amgen, Celgene, Gilead Sciences, Regeneron
One Of Pharma's Biggest Enemies Goes After The Future's Best-Selling Drug
Forbes
Mon, 03/24/14 - 08:52 am
Tags:
drug pricing, Henry Waxman, Sovaldi, Gilead Sciences
Gilead offers Egypt new hepatitis C drug at 99 pct discount
Yahoo/Reuters
Sat, 03/22/14 - 11:48 am
Tags:
Gilead Sciences, hepatitis C, Sovaldi
Biotech Tweets of the Week: Gilead Sciences and Orexigen
Motley Fool
Sat, 03/22/14 - 11:32 am
Tags:
Gilead Sciences, Orexigen
Biotech Stocks Weak on Fear That Gilead Drug Pricing Woes Will Spread
TheStreet.com
Fri, 03/21/14 - 11:56 am
Tags:
drug pricing, Gilead Sciences, Sovaldi, biotech, hepatitis C
What the Heck Happened (Again) to Biotech?
Barron's
Fri, 03/21/14 - 11:55 am
Tags:
biotech, Gilead Sciences, Biogen Idec
U.S. lawmakers ask Gilead about Sovaldi pricing
Yahoo/Reuters
Fri, 03/21/14 - 11:54 am
Tags:
drug pricing, Sovaldi, hepatitis C, Gilead Sciences
Read This Twitter Chat About Gilead and the Cost of its Hep C Drug
TheStreet.com
Fri, 03/21/14 - 09:02 am
Tags:
social media, twitter, hepatitis C, Sovaldi, Gilead Sciences, drug pricing
Pharmacyclics Drug Imbruvica Beats Rivals: Nomura
Investors.com
Thu, 03/20/14 - 05:26 pm
Tags:
Imbruvica, Pharmacyclics, Gilead Sciences, Biogen Idec, chronic lymphocytic leukemia
Big Pharma Ramps Up Hep C Strategies
Yahoo/Investors Business Daily
Wed, 03/19/14 - 07:22 pm
Tags:
hepatitis C, Sovaldi, Gilead Sciences, daclatasvir, Bristol-Myers Squibb, AbbVie, Enanta Pharmaceuticals
Sovaldi's Terrific Launch
Seeking Alpha
Mon, 03/17/14 - 10:35 am
Tags:
drug launches, Sovaldi, hepatitis C, Gilead Sciences
Health-Care Stocks: Growing Like Gangbusters
Motley Fool
Sat, 03/15/14 - 10:06 am
Tags:
Regeneron, Sanofi, Gilead Sciences, Celgene, Allergan
Gilead's hot-selling Sovaldi draws more patent attacks
Fierce Pharma
Fri, 03/14/14 - 11:15 am
Tags:
Sovaldi, Idenix, Merck, Roche, hepatitis C, patents, Gilead Sciences

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.